These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26612221)

  • 1. Diagnosis of Bladder Carcinoma: A Clinician's Perspective.
    Harshman LC; Preston MA; Bellmunt J; Beard C
    Surg Pathol Clin; 2015 Dec; 8(4):677-85. PubMed ID: 26612221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.
    Coblentz TR; Mills SE; Theodorescu D
    Cancer; 2001 Apr; 91(7):1284-90. PubMed ID: 11283928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of treatment for muscle infiltrating transitional cell bladder cancer.
    Whitmore WF
    Arch Esp Urol; 1990; 43 Suppl 2():219-22. PubMed ID: 2096783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer.
    Scher HI
    J Urol; 1994 Aug; 152(2 Pt 1):574-5. PubMed ID: 8015114
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interdisciplinary strategies for the treatment of bladder cancer].
    Bauer W; Lamche M; Schramek P
    Wien Med Wochenschr; 2007; 157(7-8):153-6. PubMed ID: 17492411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathologist's role in multidisciplinary management of bladder cancer.
    Szakacs JE; Pow-Sang J
    Ann Clin Lab Sci; 1994; 24(6):481-8. PubMed ID: 7847776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of high-risk, non-muscle-invasive bladder cancer.
    Lerner SP
    Nat Clin Pract Urol; 2006 Aug; 3(8):398-9. PubMed ID: 16902498
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bladder carcinoma].
    Lycklama à Nijeholt AA
    Ned Tijdschr Geneeskd; 1992 Jun; 136(23):1097-102. PubMed ID: 1603169
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis of and therapy for non-muscle-invasive bladder cancer - state of the art].
    Kausch von Schmeling I
    Aktuelle Urol; 2010 Sep; 41(5):307-15. PubMed ID: 20824576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder preserving approach for muscle invasive bladder cancer--role of mycobacterium w.
    Chaudhuri P; Mukhopadhyay S
    J Indian Med Assoc; 2003 Sep; 101(9):559-60. PubMed ID: 15168998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.
    Rouprêt M; Seisen T; Compérat E; Larré S; Mazerolles C; Gobet F; Fetissof F; Fromont G; Safsaf A; d'Arcier BF; Celhay O; Validire P; Rozet F; Irani J; Soulié M; Pfister C;
    J Urol; 2013 Jun; 189(6):2069-76. PubMed ID: 23201497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostatic transitional cell carcinoma: pathologic features and clinical management.
    Shen SS; Lerner SP
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1155-62. PubMed ID: 18028024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome of high-grade non-muscle-invasive bladder cancer: a long-term single center experience.
    Iida S; Kondo T; Kobayashi H; Hashimoto Y; Goya N; Tanabe K
    Int J Urol; 2009 Mar; 16(3):287-92. PubMed ID: 19207115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of muscle-invasive bladder cancer in Victoria, 1990-1995.
    Millar JL; Frydenberg M; Toner G; Syme R; Thursfield V; Giles GG;
    ANZ J Surg; 2006 Mar; 76(3):113-9. PubMed ID: 16626343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of T2 muscle-invasive bladder cancer treated with neoadjuvant chemotherapy.
    Gilbert SM; Lee CT
    Nat Clin Pract Urol; 2006 Dec; 3(12):675-9. PubMed ID: 17149384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ conservation in deeply invasive bladder cancer.
    Fair WR
    Prog Clin Biol Res; 1991; 370():119-26. PubMed ID: 1924440
    [No Abstract]   [Full Text] [Related]  

  • 18. Urinary bladder cancer: role of MR imaging.
    Verma S; Rajesh A; Prasad SR; Gaitonde K; Lall CG; Mouraviev V; Aeron G; Bracken RB; Sandrasegaran K
    Radiographics; 2012; 32(2):371-87. PubMed ID: 22411938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer.
    Tran E; Souhami L; Tanguay S; Rajan R
    Am J Clin Oncol; 2009 Aug; 32(4):333-7. PubMed ID: 19381080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial Comment to Cancer death from non-muscle invasive bladder cancer: Report of the Japanese Urological Association of data from the 1999-2001 registry in Japan.
    Koga F
    Int J Urol; 2010 Nov; 17(11):913. PubMed ID: 20969638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.